Advanced

Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.

Nygård, Mari; Hansen, Bo Terning; Dillner, Joakim LU ; Munk, Christian; Oddsson, Kristján; Tryggvadottir, Laufey; Hortlund, Maria LU ; Liaw, Kai-Li; Dasbach, Erik J and Kjær, Susanne Krüger (2014) In PLoS ONE 9(2).
Abstract
Infection with high-risk human papillomavirus (HPV) is causally related to cervical, vulvar and vaginal pre-invasive neoplasias and cancers. Highly effective vaccines against HPV types 16/18 have been available since 2006, and are currently used in many countries in combination with cervical cancer screening to control the burden of cervical cancer. We estimated the overall and age-specific incidence rate (IR) of cervical, vulvar and vaginal cancer and pre-invasive neoplasia in Denmark, Iceland, Norway and Sweden in 2004-2006, prior to the availability of HPV vaccines, in order to establish a baseline for surveillance. We also estimated the population attributable fraction to determine roughly the expected effect of HPV16/18 vaccination on... (More)
Infection with high-risk human papillomavirus (HPV) is causally related to cervical, vulvar and vaginal pre-invasive neoplasias and cancers. Highly effective vaccines against HPV types 16/18 have been available since 2006, and are currently used in many countries in combination with cervical cancer screening to control the burden of cervical cancer. We estimated the overall and age-specific incidence rate (IR) of cervical, vulvar and vaginal cancer and pre-invasive neoplasia in Denmark, Iceland, Norway and Sweden in 2004-2006, prior to the availability of HPV vaccines, in order to establish a baseline for surveillance. We also estimated the population attributable fraction to determine roughly the expected effect of HPV16/18 vaccination on the incidence of these diseases. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
PLoS ONE
volume
9
issue
2
publisher
Public Library of Science
external identifiers
  • pmid:24505474
  • wos:000330829200175
  • scopus:84895527008
ISSN
1932-6203
DOI
10.1371/journal.pone.0088323
language
English
LU publication?
yes
id
bb2d19fd-e9bd-4ca3-ba27-6cf3d7647260 (old id 4335407)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/24505474?dopt=Abstract
date added to LUP
2014-03-06 19:39:23
date last changed
2017-08-13 04:00:39
@article{bb2d19fd-e9bd-4ca3-ba27-6cf3d7647260,
  abstract     = {Infection with high-risk human papillomavirus (HPV) is causally related to cervical, vulvar and vaginal pre-invasive neoplasias and cancers. Highly effective vaccines against HPV types 16/18 have been available since 2006, and are currently used in many countries in combination with cervical cancer screening to control the burden of cervical cancer. We estimated the overall and age-specific incidence rate (IR) of cervical, vulvar and vaginal cancer and pre-invasive neoplasia in Denmark, Iceland, Norway and Sweden in 2004-2006, prior to the availability of HPV vaccines, in order to establish a baseline for surveillance. We also estimated the population attributable fraction to determine roughly the expected effect of HPV16/18 vaccination on the incidence of these diseases.},
  articleno    = {e88323},
  author       = {Nygård, Mari and Hansen, Bo Terning and Dillner, Joakim and Munk, Christian and Oddsson, Kristján and Tryggvadottir, Laufey and Hortlund, Maria and Liaw, Kai-Li and Dasbach, Erik J and Kjær, Susanne Krüger},
  issn         = {1932-6203},
  language     = {eng},
  number       = {2},
  publisher    = {Public Library of Science},
  series       = {PLoS ONE},
  title        = {Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.},
  url          = {http://dx.doi.org/10.1371/journal.pone.0088323},
  volume       = {9},
  year         = {2014},
}